Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 15 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Asc)]
Φίλτρα: Συντάκτης is Patoulias, D  [Clear All Filters]
2020
Patoulias, D., & Papadopoulos C. (2020).  Acute heart failure, type 2 diabetes and loop diuretic use: any adjunct role for sodium-glucose cotransporter-2 inhibitors?.
Patoulias, D., & Papadopoulos C. (2020).  Glucagon-like peptide-1 receptor agonists or sodium–glucose cotransporter-2 inhibitors as add-on therapy for patients with type 2 diabetes? A systematic review and meta-analysis of surrogate metabolic endpoints.
Patoulias, D., & Papadopoulos C. (2020).  Meta-Analysis Assessing the Cardiovascular Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors According to Baseline Treatment of Interest.
Patoulias, D., & Papadopoulos C. (2020).  Meta-Analysis Assessing the Effects of Allopurinol on Left Ventricular Mass and Other Indices of Left Ventricular Remodeling as Evaluated by Cardiac Magnetic Resonance Imaging..
Patoulias, D., & Papadopoulos C. (2020).  Meta-analysis Evaluating the Risk of Atrial Fibrillation With Newer Antidiabetics Across the Cardiovascular and Renal Outcome Trials.
Patoulias, D., & Papadopoulos C. (2020).  Meta-analysis of Dedicated Renal Outcome Trials Assessing the Cardio-renal Efficacy of Sodium-Glucose Co-transporter-2 Inhibitors in Patients With Chronic Kidney Disease and Albuminuria.
Patoulias, D., & Papadopoulos C. (2020).  Pericardial fat in type 2 diabetes: not just a biomarker, but a promising treatment target?.
Patoulias, D., & Papadopoulos C. (2020).  Postdischarge antidiabetic treatment in patients with type 2 diabetes and acute coronary syndrome: Time for a change?.
Patoulias, D., & Papadopoulos C. (2020).  Postdischarge antidiabetic treatment in patients with type 2 diabetes and acute coronary syndrome: Time for a change?.
Patoulias, D., & Papadopoulos C. (2020).  Prognostic value of arterial stiffness measurements in cardiovascular disease, diabetes, and its complications: The potential role of sodium-glucose co-transporter-2 inhibitors.
Patoulias, D., & Papadopoulos C. (2020).  Sodium-glucose co-transporter-2 inhibitors, cardiovascular outcomes and the impact of gender: Class effect or statistical play of chance?.
Patoulias, D., & Papadopoulos C. (2020).  Sodium–Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions.
Patoulias, D., & Papadopoulos C. (2020).  Time to assess the effects of sodium–glucose co-transporter-2 inhibitors on the ‘forgotten' right ventricle?.
Patoulias, D., & Papadopoulos C. (2020).  Updated Meta-analysis Assessing the Effect of Sodium-Glucose Co-transporter-2 Inhibitors on Surrogate End points in Patients With Heart Failure With Reduced Ejection Fraction.
Patoulias, D., & Papadopoulos C. (2020).  Updated Meta-Analysis of Trials Assessing the Cardiovascular Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Black Patients.

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές